Comparative Analysis of Cost-effectiveness Between Sulfonylureas and DPP4 Inhibitors in Combination With Metformin in Treatment of Type 2 Diabetic Patients : A Retrospective, Observational Study.

ConditionType 2 Diabetes Mellitus (T2DM), Cost-effectiveness, Sulfonylureas, DPP4 Inhibitors, Metformin

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorBangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

About this trial

The aim of this study is to compare the cost effectiveness of Sulfonylureas and DPP4-inhibitors in combination with Metformin among type2 diabetic patients diagnosed for 2-5 years. Glycemic status and other clinical outcome are compared in between two groups and ICER are compared.

Eligibility criteria

Qualifiers

New onset type2 diabetes mellitus diagnosed for 2 -5 years.

Taking either sulfonylurea or DPP4 inhibitors combined with Metformin from the time of diagnosis.

Age 18 years or above.

Both male and female.

Disqualifiers

Unwillingness to participate or unwillingness to give written informed consent.

Patients on Insulin therapy or monotherapy with metformin since the time of diagnosis.

Taking other than sulfonylurea or DPP4 inhibitors combined with Metformin from the time of diagnosis.

Diabetes related complications at the time of diagnosis.

Trial design

Treatments tested in this trial

sulfonylurease with metformin, DPP4 inhibitors with Metformin

Treatment groups

200 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Lead sponsor

Source ClinicalTrials.gov